Claims
- 1. The bioactive substance TKR1785 of the following generael formula (A) or a pharmacologically acceptable salt thereof: ##STR5## wherein R represents --CH(CH.sub.3).sub.2 or --CH(CH.sub.3)C.sub.2 H.sub.5.
- 2. A method for treating an allergic disease which comprises administering the bioactive substance TKR1785 or a pharmacologically acceptable salt thereof as defined in claim 1 at an amount effective for treating said allergic disease.
- 3. A method for modulating an immune reaction which comprises administering the bioactive substance TKR1785 or a pharmacologically acceptable salt thereof as defined in claim 1 at an amount effective for modulating an immune reaction.
- 4. A method for inhibiting growth of fungus which comprises administering the bioactive substance TKR 1785 or a pharmaceutically acceptable salt thereof as defined in claim 1 at an antifungal effective amount.
- 5. A pharmaceutical composition comprising the bioactive substance TKR1785 or a pharmacologically acceptable salt thereof.
- 6. A method of producing the bioactive substance TKR1785 which comprises culturing a strain of microorganism belonging to the genus Penicillium and capable of producing the bioactive substance TKR1785 and isolating the substance from the resulting culture broth.
- 7. A microorganism belonging to the genus Penicillium and capable of producing the bioactive substance TKR1785.
Priority Claims (1)
Number |
Date |
Country |
Kind |
8-084712 |
Mar 1996 |
JPX |
|
CROSS-REFERENCES TO RELATED APPLICATIONS
This application is a U.S. national phase application under 35 USC 371 of PCT/JP97/00770 filed Mar. 12, 1997 which in turn claims priority from Japanese Application Hei-8-84712 filed Mar. 12, 1996.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/JP97/00770 |
3/12/1997 |
|
|
10/29/1998 |
10/29/1998 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO97/34012 |
9/18/1997 |
|
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
2 135 668 |
Sep 1984 |
GBX |